Mild glucose intolerance during pregnancy may herald cardiovascular disease, according to the results of a retrospective, population-based cohort study in 435,700 Canadian women.
Mild glucose intolerance during pregnancy may herald cardiovascular disease, according to the results of a retrospective, population-based cohort study in 435,700 Canadian women.
Compared with those who were not given the test because they had a normal result on a glucose challenge test, women in the study who did not have diabetes but who were administered an oral glucose tolerance test because of an abnormal result on a 50-g glucose challenge test were almost 20% more likely within the 12.3-year median follow-up period to be admitted to a hospital for acute myocardial infarction, coronary bypass, coronary angiogram, stroke, or carotid endarterectomy (adjusted hazard ratio [HR], 1.19; 95% confidence interval [CI], 1.02-1.39; P=.03).
The study included women in Ontario, Canada, between the ages of 20 and 49 years who delivered a live fetus between April 1994 and March 1998 and did not have pregestational diabetes. Approximately 350,000 of the women did not receive an oral glucose tolerance test because they had a normal result on a challenge test. About 72,000 women received an antepartum oral glucose tolerance test because of an abnormal result on a glucose challenge test, and almost 14,000 women were diagnosed with gestational diabetes. All of the women were followed for a mean of 12.3 years.
Retnakaran R, Shah BR. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. CMAJ. 2009;181(6-7):371-376.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More